Pakistan’s Drug Regulatory Authority (DRAP) has requested the Pakistan Telecommunication Authority (PTA) to take strict action against websites and social media platforms involved in the illegal sale of unregistered medicines. The move aims to curb growing concerns over public health risks linked to unauthorized drug sales online.
Focus on illegal Online Drug Market
According to DRAP, a number of online platforms are actively promoting and selling medicines that have not been approved or registered by the regulatory body. These products may not meet safety, quality, or efficacy standards, posing serious risks to consumers.
Health and Safety Concerns
Officials have warned that unregistered medicines can lead to severe health complications, incorrect treatments, and potential drug abuse. DRAP emphasized that such products bypass essential safety checks, making them dangerous for public use.
Role of PTA Requested
DRAP has asked the PTA to block or remove websites and social media pages that are involved in the illegal sale of medicines. The authority believes that stronger digital monitoring is necessary to prevent the spread of unregulated pharmaceutical products online.
Crackdown on Digital Platforms
The crackdown specifically targets online sellers operating through e-commerce sites, Facebook pages, and other social media channels. Authorities are working to identify and shut down such platforms to protect consumers from fraud and unsafe medical products.
Call for Public Awareness
Officials have also urged the public to avoid purchasing medicines from unauthorized online sources and to rely only on licensed pharmacies. DRAP stressed that public awareness is key to preventing health risks associated with counterfeit or unregistered drugs.